Drugs News and Research

RSS

Calls for FDA to pay more attention to products made with nanotechnology

At a meeting called by the U.S. Food and Drug Administration (FDA), consumer and environmental groups have called for the FDA to pay more attention to products made by using nanotechnology.

11 Oct 2006

Cocktail of two drugs heals damaged hearts

A cocktail of drugs has been found in trials with animals to heal damaged heart muscle.

10 Oct 2006

WHO and sanofi-aventis expand programme to fight neglected tropical diseases

The World Health Organization (WHO) is expanding its program to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.

10 Oct 2006

Experts say "schizophrenia label" a harmful concept which should be dropped

British mental health experts say the term schizophrenia should abandoned as it has little scientific validity, and is imprecise and stigmatizing.

From The University of Manchester 10 Oct 2006

Mediterranean diet shown to protect against Alzheimer's

A new study has added to the growing body of research which suggests that eating a Mediterranean diet can help to prevent Alzheimer's disease.

10 Oct 2006

A pill a day gives renewed hope for breast cancer victims

A new breast cancer 'wonder drug' could be available to British women within a matter of months.

9 Oct 2006

Photochemistry creates drug-trapping nanoparticles

Many of the most potent anticancer agents are poorly soluble in water, presenting a challenge for medicinal chemists who must develop methods of delivering these drugs in the watery environment of the human body.

9 Oct 2006

Nanoparticle encapsulation improves bioavailability of leukemia drug

Busulfan, which belongs to a family of drugs known as alkylating agents, is used to treat hematological malignancies, including chronic myelogenous leukemia.

9 Oct 2006

Generic hypertension drug a suspect in 19 deaths in Panama

As a result of a mystery illness that has claimed the lives of 19 people, officials in Panama have withdrawn all stocks of a hypertension drug used by thousands to treat high blood pressure.

9 Oct 2006

Federal Agencies collected $1.47B in fraud from government health insurance programs in FY 2005

The Department of Justice and the HHS Office of Inspector General in a report issued this week announced that their joint Health Care Fraud and Abuse Control Program -- which attempts to reduce waste, fraud and abuse in federal health care programs -- will collect $1.47 billion from criminal or civil cases brought during fiscal year 2005, The Hill reports.

8 Oct 2006

National Eye Institute to finance two-year study comparing effectiveness of treatments for macular degeneration

The National Eye Institute on Thursday said it will finance a two-year study comparing the effectiveness of Genentech's eye treatment Lucentis and cancer drug Avastin for treating wet age-related macular degeneration, the New York Times reports.

8 Oct 2006

FDA approves Risperdal to treat irritability associated with autism

The U.S. Food and Drug Administration (FDA) has approved Risperdal (risperidone) orally disintegrating tablets, an adult antipsychotic drug, for the symptomatic treatment of irritability in autistic children and adolescents.

8 Oct 2006

New York State law prevents new CDC testing recommendations from being implemented

A New York state law passed in the 1980s prevents the state from implementing CDC's revised recommendations on HIV testing in the U.S. that say HIV tests should become a routine part of medical care for residents ages 13 to 64 and that requirements for written consent and pretest counseling should be dropped, the New York Times reports.

5 Oct 2006

India doubles treatment centers offering HIV/AIDS drugs at no cost

India has nearly doubled the number of government health facilities offering antiretroviral drugs at no cost to HIV-positive people as part of a campaign to increase access to HIV/AIDS treatment, Sujatha Rao, head of India's National AIDS Control Organization, said recently, the AP/Boston Herald reports (George, AP/Boston Herald).

5 Oct 2006

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.

5 Oct 2006

Ho Chi Minh City to expand access to HIV/AIDS treatment for pregnant women

Ho Chi Minh City, Vietnam, will expand access to no-cost HIV/AIDS treatment for pregnant women to prevent mother-to-child transmission of HIV, city health officials said Saturday, Vietnam News Service/Viet Nam News reports (Vietnam News Service/Viet Nam News).

5 Oct 2006

U.S. Customs to stop seizing Canadian drugs

U.S. Customs and Border Protection officials on Tuesday said that as of Oct. 9 they will no longer seize prescription drugs sent by mail to U.S. residents from Canadian pharmacies, the Wall Street Journal reports (Carreyrou, Wall Street Journal, 10/4).

5 Oct 2006

U.S. must do more to protect integrity of pharmaceuticals

The business of counterfeit prescription drugs "has grown to frightening proportions," and the U.S. must do more to "protect the integrity of pharmaceuticals dispensed" in the nation, Henry Miller, a physician and Hoover Institution fellow, writes in a Washington Times opinion piece.

5 Oct 2006

NIH funds study that may prevent cognitive dysfunctions among HIV-positive people

NIH is funding a recent effort aimed at studying drugs that might prevent dementia and other cognitive dysfunctions among HIV-positive people, a condition also known as "neuroAIDS," the AP/ABC News reports.

5 Oct 2006

Window of opportunity to control the spread of HIV in Angola

Health officials are taking advantage of the "window of opportunity" to control the spread of HIV in Angola since the civil war ended in 2002, Reuters reports.

5 Oct 2006